Dr. Richard Vaglienti of the West Virginia University Medicine Pain Clinic said he agrees somewhat with the new law because prescriptions are down.
“Much of that is due to restrictions on physicians at the state and federal level. Doctors are afraid of being sanctioned. Eventually non-opioid forms of treatment will take over,” Vaglienti said. “We offer an integrated pain center with all kinds of treatment under one roof — chiropractors, counselors, physical therapists and massage therapists who we can use in place of pain pills.”
“It runs based on best practices,” Robin Pollini, the associate director of the Injury Control Research Center at West Virginia University, said about KCHD’s program. “I’ve sat in the rooms and listened to the interactions that take place. The policies that they follow are the policies that any sort of model program follows.” Pollini has spent 18 years studying injection drug users and the services they get at needle exchanges and other programs and has worked with syringe exchange programs all over the country, she said. Pollini said the fact that the health department also offers primary care is extraodinary because patients often have problems getting from place to place to get other services.
The overdose data shows a sharp rise in non-opioid drug deaths. Methamphetamine overdoses nearly doubled in one year, from 107 in 2016 to 198 last year. Amphetamine-related showed a similar increase, from 117 to 209. Meth addicts are more likely to commit violent crimes, and they’re more resistant to entering drug treatment programs, according to police and health care workers. “We are concerned, as law enforcement tells us, there is a lot more meth happening,” Gupta said. “It’s a concerning trend.”
Friday, April 27, 2018 from 02:00 PM – 03:00 PM
This panel presentation will look at various aspects of opioid use and its relationship with the disability population.
Panel members from various disciplines will:
- Outline and discuss maternal opioid use and potential impact on development disability rates.
- Explore existing evidence and potential gaps related to opioid use among individuals with acute or chronic disabilities.
- Discuss needed next steps in practice, research, and policy focused on opioid effects for this population.
Andrew Imparato, JD– Executive Director, Association of University Centers on Disabilities
Lauren Swager, MD – Associate Professor Director Child & Adolescent Psychiatry Fellowship, WVU Chestnut Ridge Hospital
Mark Cody Smith, MD – Assistant Professor, Associate Program Director – WVU Neonatal Fellowship Program
Christina Mulins, Director, Office of Maternal, Child and Family Health, WV Department of Health and Human Resources
Weston Kensinger, Ph.D – Assistant Teaching Professor of Health Education, School of Behavioral Sciences and Education Professor-in-Charge, Health Education Graduate Program, Penn State Harrisburg
This event is free and open to the public.
Friday, April 27, 2018 at 2:00
WVU Health Science Center – Room 1909
The battle against opioids is being fought on many different angles. Prevention and education play a key role in limiting the presence of opioids in our communities. New laws in West Virginia create standards for physicians, pharmacists and healthcare professionals when it comes to prescribing and dispensing opioids. Limiting the amount of opioids prescribed can be as simple as using Tylenol and Motrin as supplements to treat pain.
Source: United Hospital Center explores alternatives to pain medications
Maternal Comprehensive Opioid Addiction Treatment, a new program launched by WVU Medicine at the Harpers Ferry Family Medical Center, is aiming to tackle the obstacles expectant mothers face on the journey to getting clean, as reported Thursday in The Journal.
Run by Dr. David Baltierra and Giselle Perry, a licensed practical nurse and program therapist, the pilot program features medical treatment paired with group therapy on substance abuse, relapse prevention, pre-natal care, breast feeding, pain management and and actual labor and delivery, according the Thursday’s Journal article.
Joshua Gross, a doctoral candidate in the Siderovski lab of the WVU School of Medicine, received a National Institutes of Health grant to study a protein that influences the brain’s response to psycho-stimulant drugs…